{"schema_version":"1","generated_at":"2026-10-29T13:29:29.063Z","data_as_of":"2026-10-25","url":"https://www.findmykol.com/kol/aparna-goel","json_url":"https://www.findmykol.com/kol/aparna-goel/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"aparna-goel","name":"Aparna Goel","credential":"MD","title":"Clinical Associate Professor, Gastroenterology and Hepatology, Stanford (2022-present)","specialty":"Gastroenterology","specialty_raw":"Gastroenterology","therapeutic_area":"Gastroenterology","therapeutic_areas":["Gastroenterology"],"institution":"Stanford University School of Medicine","institution_url":"https://www.findmykol.com/institution/stanford-university-school-of-medicine","city":"Stanford","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1619104411","orcid":"0000-0001-9588-9364","openalex":"A5026980871"},"summary":"Aparna Goel is Clinical Associate Professor, Gastroenterology and Hepatology, Stanford (2022-present) at Stanford University School of Medicine. OpenAlex indexes 126 publications with 1,664 citations (h-index 20); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"Aparna Goel, MD, is Clinical Associate Professor, Gastroenterology and Hepatology, Stanford (2022-present) at Stanford University School of Medicine. The public record shows 126 publications with 1,664 citations (h-index 20), centered on Liver Diseases and Immunity, Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies.","bullets":["Most recent indexed publication: 2026 · Hepatology (Baltimore, Md.)","Top research focus: Liver Diseases and Immunity","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 8 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Cholangitis","therapeutic_area":"Gastroenterology","trials":2,"topics":0,"strength":6},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":1,"topics":1,"strength":4},{"label":"Hepatitis C","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Liver Diseases","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Liver Cirrhosis","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Ascites","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Liver Cirrhosis, Biliary","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Cholangitis, Sclerosing","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3}],"research_topics":["Liver Diseases and Immunity","Liver Disease and Transplantation","Organ Transplantation Techniques and Outcomes","Pediatric Hepatobiliary Diseases and Treatments","Hepatitis C virus research"],"drugs_studied":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Livdelzi","generic":"Seladelpar","trials":0,"payments":5,"publications":3,"mentions":8},{"name":"Ocaliva","generic":"Obeticholic acid","trials":0,"payments":7,"publications":1,"mentions":8},{"name":"Livmarli","generic":"Maralixibat","trials":0,"payments":25,"publications":0,"mentions":25}]},"works_with":{"total":10,"shown":3,"withheld":7,"rows":[{"name":"Mirum Pharmaceuticals, Inc.","trials":0,"payments":25,"mentions":25},{"name":"Ipsen Biopharmaceuticals, Inc","trials":0,"payments":13,"mentions":13},{"name":"Gilead Sciences, Inc.","trials":0,"payments":9,"mentions":9}]}},"scholarship":{"works_count":126,"cited_by_count":1664,"h_index":20,"i10_index":35,"pubmed_count":18,"latest_activity_year":2026,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07631442","title":"Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC)","status":"ENROLLING_BY_INVITATION","role":"Investigator","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT07631442","trial_url":"https://www.findmykol.com/trial/NCT07631442"},{"nct":"NCT05295680","title":"Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Aparna Goel","source_url":"https://clinicaltrials.gov/study/NCT05295680","trial_url":"https://www.findmykol.com/trial/NCT05295680"},{"nct":"NCT05013502","title":"Empagliflozin in Diuretic Refractory Ascites","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT05013502","trial_url":"https://www.findmykol.com/trial/NCT05013502"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":2025},"rows_total":15,"shown":3,"withheld":12,"rows":[{"payer":"Ipsen Biopharmaceuticals, Inc","program_year":2025,"amount_usd":13254.17,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619104411"},{"payer":"Mirum Pharmaceuticals, Inc.","program_year":2025,"amount_usd":7611.73,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619104411"},{"payer":"Intercept Pharmaceuticals, Inc.","program_year":2025,"amount_usd":6480,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619104411"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1619104411","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"AASLD AGA clinical Practice Guideline on management of primary biliary cholangitis.","year":2026,"journal":"Hepatology (Baltimore, Md.)","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42910434/","status":"verified"},{"title":"Advances in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.","year":2026,"journal":"Seminars in liver disease","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42743991/","status":"verified"},{"title":"Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.","year":2026,"journal":"The American journal of gastroenterology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41769906/","status":"verified"},{"title":"LiverPRO: a new screening test for fibrosis in steatotic liver disease.","year":2026,"journal":"Translational gastroenterology and hepatology","types":["Editorial","Comment"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41675334/","status":"verified"},{"title":"A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers.","year":2025,"journal":"Hepatology communications","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40227093/","status":"verified"}],"most_cited":{"total":126,"shown":5,"withheld":121,"rows":[{"title":"Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States—A Single-Center Experience","year":2015,"cited_by_count":254,"type":"article","source_url":"https://doi.org/10.1111/ajt.13586"},{"title":"Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy","year":2013,"cited_by_count":150,"type":"article","source_url":"https://doi.org/10.1002/lt.23753"},{"title":"The features of mucosa‐associated microbiota in primary sclerosing cholangitis","year":2016,"cited_by_count":149,"type":"article","source_url":"https://doi.org/10.1111/apt.13552"},{"title":"Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group","year":2020,"cited_by_count":117,"type":"article","source_url":"https://doi.org/10.1016/j.cgh.2020.10.026"},{"title":"A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis","year":2022,"cited_by_count":82,"type":"article","source_url":"https://doi.org/10.1016/j.jhep.2022.02.033"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Aijaz Ahmed","coauthored_works":23,"profile_url":"https://www.findmykol.com/kol/aijaz-ahmed"},{"name":"Marlyn J. Mayo","coauthored_works":22},{"name":"Cynthia Levy","coauthored_works":22,"profile_url":"https://www.findmykol.com/kol/cynthia-levy"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/aparna-goel-md","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://altais.com/physicians/aparna-goel-md-1619104411/","status":"provisional","collected_at":"2026-10-28"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Annual Division Teaching Award, Stanford Department of Medicine (2020)","source_url":"https://profiles.stanford.edu/aparna-goel","status":"verified","collected_at":"2026-10-28"},{"value":"Member, Alpha Omega Alpha, Jefferson Medical College (2008)","source_url":"https://profiles.stanford.edu/aparna-goel","status":"verified","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Stanford Children's Health, Gastroenterology, Nutrition & Hepatology (Palo Alto, CA)","source_url":"https://altais.com/physicians/aparna-goel-md-1619104411/","status":"provisional","collected_at":"2026-10-28"}]}},"similar":[{"name":"Glenn Chertow","slug":"glenn-chertow","institution":"Stanford University School of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/glenn-chertow","json_url":"https://www.findmykol.com/kol/glenn-chertow/profile.json"},{"name":"Paul Heidenreich","slug":"paul-heidenreich","institution":"Stanford University School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/paul-heidenreich","json_url":"https://www.findmykol.com/kol/paul-heidenreich/profile.json"},{"name":"Alan Schatzberg","slug":"alan-schatzberg","institution":"Stanford University School of Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/alan-schatzberg","json_url":"https://www.findmykol.com/kol/alan-schatzberg/profile.json"},{"name":"Maximilian Diehn","slug":"maximilian-diehn","institution":"Stanford University School of Medicine","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/maximilian-diehn","json_url":"https://www.findmykol.com/kol/maximilian-diehn/profile.json"},{"name":"Charles Rice","slug":"charles-rice","institution":"The Rockefeller University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/charles-rice","json_url":"https://www.findmykol.com/kol/charles-rice/profile.json"},{"name":"Edward Loftus","slug":"edward-loftus","institution":"Mayo Clinic Rochester","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/edward-loftus","json_url":"https://www.findmykol.com/kol/edward-loftus/profile.json"},{"name":"Naga Chalasani","slug":"naga-chalasani","institution":"Indiana University School of Medicine","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/naga-chalasani","json_url":"https://www.findmykol.com/kol/naga-chalasani/profile.json"},{"name":"Bruce Sands","slug":"bruce-sands","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/bruce-sands","json_url":"https://www.findmykol.com/kol/bruce-sands/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":12,"publications":13,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}